Home › Acute Lymphoblastic Leukemia › Washington › Spokane
Acute Lymphoblastic Leukemia clinical trials in Spokane, WA
3 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Cancer Care Northwest - Spokane South, Spokane
- Cancer Care Northwest-Valley, Spokane
- Cancer Care Northwest-North Spokane, Spokane
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Chicago, IL19 studies
- Atlanta, GA19 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease7 studies
- Prostate Cancer6 studies
- Chronic Lymphocytic Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Cancer (all types)6 studies
- Triple-Negative Breast Cancer5 studies
- Melanoma5 studies
- Macular Degeneration5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.